Latest Ndis News

Bridge SaaS sharpened its strategic focus on NDIS software and AI research following a $1.5 million divestment of Brightside, while preparing a $3.5 million capital raise to support its NSW operations and technology development.

Bridge SaaS Limited has exited its non-core investment in Brightside Disability Support, recouping its initial outlay and sharpening its focus on AI-driven disability services and robotics innovation.

Control Bionics progresses its scalable distributor-led model in North America, inks a strategic US partnership for iOS speech devices, and gains German reimbursement eligibility for NeuroNode, while managing cash flow amid NDIS delays.

FBR Limited has locked in a binding $400,000–$450,000 Wall as a Service® contract with AMOVEO, marking a key step in deploying its Hadrian® robotic construction technology at scale. The company also inked a strategic MOU to pilot a hybrid robotic-modular housing solution targeting Australia’s affordable housing shortage.

McMillan Shakespeare Limited reported a 9.7% rise in statutory net profit for the first half of FY26, driven by strong revenue growth and productivity gains. The company declared a fully franked 62 cent dividend and announced a $10 million on-market share buyback.

Thrive Tribe Technologies reported a $186,000 net operating cash outflow in Q2 FY26, offset by a $300,000 equity raise to fund growth initiatives and operational expansion.

Bridge SaaS Limited reports steady operational progress in its disability services division, highlighted by the launch of a wholly owned NSW subsidiary and solid cash flow results for the December 2025 quarter.

Mayfield Childcare Limited unveils Mayfield 360, an allied health services division aimed at integrating therapy supports within its childcare network, targeting a sizable and growing segment of the National Disability Insurance Scheme market.

Freedom Care Group Holdings has placed its main operating entity into administration following a sharp decline in cash receipts linked to delayed payments from the NDIA and an ongoing audit. The company’s cash balance dropped significantly, prompting urgent restructuring efforts.

Control Bionics has raised $3.8 million to fuel growth, forged a key distribution deal with Tobii, and integrated with Apple’s BCI protocol, while advancing its NeuroStrip and NeuroBounce platforms.

nib holdings limited signals higher-than-expected non-recurring expenses in the first half of 2026, impacting statutory profit but leaving underlying performance steady.

Control Bionics has integrated Apple’s Brain-Computer Interface protocol into its NeuroNode products, promising simpler setup and enhanced communication for users with severe impairments.